Uppsala University is the oldest university in Sweden, founded in 1477, and boasts a lively multicultural environment and extraordinary student life with over 45,000 students! World-class research and the high quality education pursued at the University are aimed at benefitting society and business on a global level. The University is characterized by both the diversity and breadth of programs offered at both Bachelor and Master level and the international frontline research taking place across nine different faculties. For more information on Uppsala University please visit the website.
Life Sciences at Uppsala
Uppsala University is part of a major new research initiative in life sciences in Sweden, SciLifeLab, with one of its central aims to explain the molecular basis of disorders in humans by applying new technologies on well-defined patient samples. The aim is to identify genetic risk factors, biomarkers, and molecular mechanisms in human diseases, providing opportunities for early diagnosis, personal treatment, and identifying points of attack for new medicines. UU also hosts Sweden’s only faculty of pharmacy that creates preconditions for vitalising and rationalising drug development. Cancer research at UU has been further advanced through the projects U-CAN & U-CARE and by interactions with UU Hospital. U-CAN builds an extensive biobank, while also devising methods to improve diagnostics, characterise malignant diseases, and select individualized treatments.
The Department of Immunology, Genetics and Pathology (IGP), as part of the SciLifeLab, focuses on research in genomics, epigenetics, cancer, diabetes, vascular biology, stem cell and immune therapy, as well as molecular technologies for purposes of improving diagnostics, prognostics and treatment as crucial elements of translational medicine. IGP contributes to the Human Proteome Atlas project, establishing a resource for novel biomarker identification, and the department includes the units Clinical Immunology, Clinical Genetics and Clinical Pathology as well as hosting the core facilities for Next Generation Sequencing (NGS) platforms, Bioimaging and cell analysis. IGP is heading the Master programme in Molecular Medicine, which is strongly linked to current research and also forms part of the IMIM curriculum.
The Department of Medical Biochemistry and Microbiology (IMBIM) conducts research and teaching in medical biochemistry/cell biology, medical microbiology/immunology, and functional genomics. Much of the research is interdisciplinary and collaborative in character. Two of the major projects are, Identification of genetic causes for human diseases using the genetics of inbred domestic animals and understanding mechanisms of antibiotics resistance and development of new antibiotics. A core facility for proteomics is present at IMBIM, and also hosted is the laboratory of the director of SciLifeLab in Uppsala. IMBIM is heading the Master Program in Medical Research which also forms part of the IMIM curriculum.